Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorDartmouth-Hitchcock Medical Center

About this trial

This pilot study aims to investigate the viability of using a smartwatch-based electrodermal activity (EDA) sensor to capture enough EDA signal to quantitatively assess pain in osteoarthritis subjects and test the feasibility of its methods and procedures for later use in subsequent larger-scale studies.

Eligibility criteria

Qualifiers

Kellgren-Lawrence Grade >= 3

Disqualifiers

Inflammatory arthropathy (e.g., rheumatoid arthritis), BMI >=35

Complaints of lower extremity joint pain

Known diagnosis of knee osteoarthpathy

Prior history of knee surgery, knee injections, or injury to knee joints (e.g., meniscus tears, ligamentous injuries), BMI >=35

Trial design

Treatments tested in this trial

  • Electrodermal Activity signal

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators

Dartmouth-Hitchcock Medical Center

Lead sponsor

University of Connecticut

Collaborator